February 26, 2015 4:06 PM ET


Company Overview of Ember Therapeutics, Inc.

Company Overview

Ember Therapeutics, Inc. offers products for the treatment of metabolic disease, including Type 2 diabetes and obesity. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was formerly known as Adipothermics Inc. Ember Therapeutics, Inc. was founded in 2011 and is based in Boston, Massachusetts.

29 Newbury Street

Boston, MA 02116

United States

Founded in 2011



Key Executives for Ember Therapeutics, Inc.

Chief Executive Officer, President and Member of The Board of Directors
Age: 50
Chief Operating Officer
Vice President of Metabolic Disease Biology
Vice President of Small Molecule Drug Discovery
Chief Scientific Officer and Member of Scientific Advisory Board
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
BioChemics, Inc. United States
Heaven Sent Naturals, Inc. United States
Tolmar Therapeutics, Inc. United States
Warrick Pharmaceuticals Corporation United States
Pathogenics, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ember Therapeutics, Inc., please visit www.embertx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.